Lähnemann, David
Köster, Johannes
Szczurek, Ewa
McCarthy, Davis J.
Hicks, Stephanie C.
Robinson, Mark D. http://orcid.org/0000-0002-3048-5518
Vallejos, Catalina A.
Campbell, Kieran R.
Beerenwinkel, Niko
Mahfouz, Ahmed
Pinello, Luca
Skums, Pavel
Stamatakis, Alexandros
Attolini, Camille Stephan-Otto
Aparicio, Samuel
Baaijens, Jasmijn
Balvert, Marleen
Barbanson, Buys de
Cappuccio, Antonio
Corleone, Giacomo
Dutilh, Bas E.
Florescu, Maria
Guryev, Victor
Holmer, Rens
Jahn, Katharina
Lobo, Thamar Jessurun
Keizer, Emma M.
Khatri, Indu
Kielbasa, Szymon M.
Korbel, Jan O.
Kozlov, Alexey M.
Kuo, Tzu-Hao
Lelieveldt, Boudewijn P.F.
Mandoiu, Ion I.
Marioni, John C.
Marschall, Tobias
Mölder, Felix
Niknejad, Amir
Rączkowska, Alicja
Reinders, Marcel
Ridder, Jeroen de
Saliba, Antoine-Emmanuel
Somarakis, Antonios
Stegle, Oliver
Theis, Fabian J.
Yang, Huan
Zelikovsky, Alex
McHardy, Alice C.
Raphael, Benjamin J.
Shah, Sohrab P.
Schönhuth, Alexander
Article History
Received: 2 August 2019
Accepted: 2 January 2020
First Online: 7 February 2020
Competing interests
: BJR is a co-founder and consultant at Medley Genomics. FJT reports receiving consulting fees from Roche Diagnostics GmbH and Cellarity Inc., and ownership interest in Cellarity, Inc. and Dermagnostix GmbH. IIM is a co-founder and holds an interest in SmplBio LLC, a company developing cloud-based scRNA-Seq analysis software. No products, services, or technologies of SmplBio have been evaluated or tested in this work. JdR is co-founder of Cyclomics BV. SA is a scientific advisor to Sangamo and Repare Therapeutics. SA and SPS are both founders and shareholders of Contextual Genomics Inc. All other authors declare that they have no competing interests.